This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Bennewith, K. L. Articles by Durand, R. E. Search for Related Content PubMed PubMed Citation Articles by Bennewith, K. L. Articles by Durand, R. E.

Orally Administered Pimonidazole to Label Hypoxic Tumor Cells¹

Medical Biophysics Department, British Columbia Cancer Research Centre, Vancouver, British Columbia, Canada [K. L. B., R. E. D.], and Department of Radiation Oncology and Toxicology, University of North Carolina School of Medicine, Chapel Hill, North Carolina 27599-7512 [J. A. R.]

Pimonidazole, a "hypoxia marker" normally delivered i.v. or i.p., was instead administered in the drinking water of tumor-bearing mice. As pimonidazole exposure was increased from 3–96 h ad libitum, both the fraction of hypoxic tumor cells and the relative number of pimonidazole adducts in those cells increased. Furthermore, the sustained ingestion of pimonidazole revealed a larger hypoxic fraction than did a single injection of an alternative hypoxia marker, CCI-103F. The "additional" hypoxia seen with longer-term oral administration apparently reflects the inclusion of transiently hypoxic tumor cells. Thus, in addition to its convenience and versatility when compared with hypoxia marker injection, oral administration of pimonidazole appears to permit identification of all of the physiologically and therapeutically relevant hypoxic tumor cells.

This article has been cited by other articles:

				L. I. Cardenas-Navia, D. Mace, R. A. Richardson, D. F. Wilson, S. Shan, and M. W. Dewhirst The Pervasive Presence of Fluctuating Oxygenation in Tumors Cancer Res., July 15, 2008; 68(14): 5812 - 5819. [Abstract] [Full Text] [PDF]

				S. Sobhanifar, C. Aquino-Parsons, E. J. Stanbridge, and P. Olive Reduced Expression of Hypoxia-Inducible Factor-1{alpha} in Perinecrotic Regions of Solid Tumors Cancer Res., August 15, 2005; 65(16): 7259 - 7266. [Abstract] [Full Text] [PDF]

				L. I. Cardenas-Navia, D. Yu, R. D. Braun, D. M. Brizel, T. W. Secomb, and M. W. Dewhirst Tumor-dependent Kinetics of Partial Pressure of Oxygen Fluctuations during Air and Oxygen Breathing Cancer Res., September 1, 2004; 64(17): 6010 - 6017. [Abstract] [Full Text] [PDF]

				K. L. Bennewith and R. E. Durand Quantifying Transient Hypoxia in Human Tumor Xenografts by Flow Cytometry Cancer Res., September 1, 2004; 64(17): 6183 - 6189. [Abstract] [Full Text] [PDF]

				R. A. Cairns and R. P. Hill Acute Hypoxia Enhances Spontaneous Lymph Node Metastasis in an Orthotopic Murine Model of Human Cervical Carcinoma Cancer Res., March 15, 2004; 64(6): 2054 - 2061. [Abstract] [Full Text] [PDF]

				S. Bassnett and R. McNulty The effect of elevated intraocular oxygen on organelle degradation in the embryonic chicken lens J. Exp. Biol., December 1, 2003; 206(23): 4353 - 4361. [Abstract] [Full Text] [PDF]